Patent Business Lawyer in Asia
Patent Attorney practicing Patents, Corporate Law, Mergers and Acquisitions, Venture Financing, Startup Technology Law
Regulatory Challenges and FDA Approval of Biosimilars – An Overview
August 12th, 2014
Biosimilars are generic versions of biologics, medicinal products with active drug component being made (or derived) from a living organism. It is complicated and cost intensive to manufacture biologics, and hence regulatory approval of biosimilars is very challenging.
Originally published here.
//storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges/embed//storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges.js[View the story “FDA Approval of Biosimilars – Regulatory Challenges” on Storify]
Advice for Contacting
Engagements: Contractual Consulting, Hourly, Project Based
Contact Mode: LinkedIn or directly message here
Previous Blog Posts on Web
http://l.yimg.com/rt/pps/listbadge_1.8.js
Previous Blog Posts on Twitter
Tweets about “#techlawblog from:rdpatentlawyer”
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+”://platform.twitter.com/widgets.js”;fjs.parentNode.insertBefore(js,fjs);}}(document,”script”,”twitter-wjs”);
This is not a legal advice: Disclaimer, Non-Solicitation & Liability
Visit Technology Law Business Blog’s profile on Pinterest.//assets.pinterest.com/js/pinit.js